References
- Ryan T J. Cutaneous vasculitis. Textbook of dermatology, 5th edn., H R Champion, L J Burton, G JF Ebling. Blackwell Scientific, London 1992; 1915–17
- Shelley B W, Shelley D E. Advanced dermatologic therapy. WB Saunders, Philadelphia 1987; 517–25
- Sams M W. Necrotizing vasculitis. Immunologic disease of the skin, R E Jordan. Appleton & Lange, Norwalk 1991; 437–49
- Fradin S M, Ellis N Ch, Voorhees J J. Management of patients and side effects during cyclosporin therapy for cutaneous disorders. J Am Acad Dermatol 1990; 23: 1265–75
- Curley R K, MacFarlane A W, Vickers C FH. Pydoderma gangrenosum treated with cyclosporin. Br J Dermatol 1985; 113: 601–4
- Salek S M, Finlay A Y, Luscombe K D, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebocontrolled trial. Br J Dermatol 1993; 4: 422–30
- Fradin S M, Ellis N Ch, Goldfard T M, Voorhees J J. Oral cyclosporin for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991; 25: 1065–7
- Elgart G, Larson K, Stover P, et al. Effective treatment of pyoderma gangrenosum with cyclosporin: a report of five cases. J Invest Dermatol 1989; 92: 424
- Vincent C H, Lui H, McLean D. Cyclosporin in nonspecific dermatoses. J Am Acad Dermatol 1990; 23: 1248–59
- Shelley D E, Shelley B W. Cyclosporin therapy for pyoderma gangrenosum associated with sclerosing cholangiitis and ulcerative colitis. J Am Acad Dermatol 1988; 18: 1084–8
- Mihatsch J M, Wolff K. Consensus conference on cyclosporin-A for psoriasis. Br J Dermatol 1992; 126: 621–3